DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 196 filers reported holding DENALI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $420,472,572 | +93006.3% | 15,119,474 | +2.7% | 0.44% | -6.0% |
| Q3 2022 | $451,605 | +3.2% | 14,715,051 | -1.0% | 0.47% | +3.8% |
| Q2 2022 | $437,606 | -9.2% | 14,869,374 | -0.7% | 0.45% | +32.8% |
| Q1 2022 | $481,921 | -28.2% | 14,980,432 | -0.5% | 0.34% | -8.2% |
| Q4 2021 | $671,515 | -11.3% | 15,056,381 | +0.3% | 0.37% | -7.1% |
| Q3 2021 | $757,245 | -36.3% | 15,009,816 | -0.9% | 0.40% | -31.6% |
| Q2 2021 | $1,188,179 | +60.1% | 15,147,613 | +16.6% | 0.58% | +39.5% |
| Q1 2021 | $742,026 | -27.3% | 12,995,197 | +6.6% | 0.42% | -26.9% |
| Q4 2020 | $1,021,056 | +163.2% | 12,190,256 | +12.6% | 0.57% | +112.7% |
| Q3 2020 | $387,938 | +72.9% | 10,827,178 | +16.7% | 0.27% | +56.1% |
| Q2 2020 | $224,371 | +40.4% | 9,279,194 | +1.6% | 0.17% | -1.2% |
| Q1 2020 | $159,861 | +20.9% | 9,129,752 | +20.3% | 0.17% | +35.2% |
| Q4 2019 | $132,221 | +17.2% | 7,590,247 | +3.1% | 0.13% | 0.0% |
| Q3 2019 | $112,809 | -26.6% | 7,363,463 | -0.6% | 0.13% | -21.5% |
| Q2 2019 | $153,773 | +5.8% | 7,407,229 | +18.3% | 0.16% | +2.5% |
| Q1 2019 | $145,408 | +13.0% | 6,262,226 | +0.6% | 0.16% | -4.8% |
| Q4 2018 | $128,665 | +7.9% | 6,227,724 | +13.5% | 0.17% | +29.5% |
| Q3 2018 | $119,275 | +46.3% | 5,486,421 | +2.7% | 0.13% | +46.6% |
| Q2 2018 | $81,506 | -20.3% | 5,344,633 | +2.9% | 0.09% | -26.7% |
| Q1 2018 | $102,247 | +32.8% | 5,192,846 | +5.5% | 0.12% | +25.0% |
| Q4 2017 | $76,976 | – | 4,921,783 | – | 0.10% | – |
Download | ||||||